Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Megace

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 14 USDMF, 8 CEP/COS, 3 KDMF, 6 NDC API, 10 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

64 FDF Dossiers, 21 FDA Orange Book, 25 Europe, 2 Canada, 16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 125MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 4 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Kirsch Pharma, 1 ACG Worldwide, 10 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 18 BASF, 2 CD Formulation, 11 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 23 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 13 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 37 Thickeners and Stabilizers, 26 Direct Compression, 24 Solubilizers, 23 Granulation, 22 Controlled & Modified Release, 20 Topical, 18 Disintegrants & Superdisintegrants, 17 Parenteral, 13 Lubricants & Glidants, 12 Rheology Modifiers, 11 Taste Masking, 11 Emulsifying Agents, 11 Co-Processed Excipients, 10 Film Formers & Plasticizers, 9 API Stability Enhancers, 7 Chewable & Orodispersible Aids, 5 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 18 Regulatory FDF Prices

MARKET PLACE

5 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM, 3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Pfizer CentreOne	U.S.A	Pharmacia & Upjohn Company Kalamazoo US	R1-CEP 2006-230 - Rev 01	Megestrol acetate	2014-04-23	Valid	Chemical		1593
29/11/2025	Axplora	Germany	FARMABIOS S.p.A Gropello Cairoli IT	CEP 2002-181 - Rev 09	Megestrol acetate, Micronised and fine powder	2024-05-30	Valid	Chemical		1593

Megace

Megace

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers

14 USDMF

8 CEP/COS

3 KDMF

6 NDC API

10 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

13 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

64 FDF Dossiers

21 FDA Orange Book

25 Europe

2 Canada

16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUSPENSION;ORAL - 125MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

3 Rochem International Inc

4 SPI Pharma

7 DKSH

1 Pharm-RX Chemical

4 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 Kirsch Pharma

1 ACG Worldwide

10 Actylis

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

18 BASF

2 CD Formulation

11 Corel Pharma Chem

6 DFE Pharma

1 Esteem Industries

2 Finar

10 Gangwal Chemicals

4 Ideal Cures

3 Ingredion Pharma Solutions

23 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

2 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

15 Roquette

13 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

3 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders

40 Coating Systems & Additives

37 Thickeners and Stabilizers

26 Direct Compression

24 Solubilizers

23 Granulation

22 Controlled & Modified Release

SUSPENSION;ORAL - 40MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons